Extract
Allelix Second Quarter Fiscal 1996 Results.
TORONTO--(BUSINESS WIRE)--April 10, 1996--ALLELIX (TSE, ME: AXB) -0-
President's Message Allelix moved its research and clinical development programs forward during the second quarter of fiscal 1996 and leaders for each of its three strategic business units were appointed during the quarter. The Protein Therapeutics business unit is being directed by Mr. Douglas Froom, Senior Vice President, Protein Therapeutics. Patient enrollment into the Phase II cli...See the full content of this document
Sponsored links
